Fundraising Fox

Genelux

NASDAQ: GNLX

Westlake Village, US · Delaware corporation

Biotech

Founders & leadership

TZ
Thomas ZindrickExecutive
PS
Paul ScigallaNamed on SEC filing
GW
Gabe WoodwardNamed on SEC filing
MM
Mary MirabelliNamed on SEC filing
JT
John ThomasNamed on SEC filing
DS
Doug SamuelsonNamed on SEC filing
JT
James TyreeNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$23.8M disclosed across 2 rounds · 2023

▶$5.5MraisedJun 2023 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mary MirabelliDirector
  • Thomas ZindrickExecutive Officer, Director
  • Doug SamuelsonExecutive Officer
  • Gabe WoodwardDirector
  • Paul ScigallaExecutive Officer
  • James TyreeDirector
  • John ThomasDirector
Offering amount
$18M
Amount sold
$5.5M
Finders' fees
$200K
First sale
Jun 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$18.3MraisedJun 2023 · 69 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul ScigallaExecutive Officer
  • Gabe WoodwardDirector
  • Thomas ZindrickExecutive Officer, Director
  • Mary MirabelliDirector
  • John ThomasDirector
  • Doug SamuelsonExecutive Officer
  • James TyreeDirector
Offering amount
$33.3M
Amount sold
$18.3M
First sale
May 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Genelux raised?
Genelux has disclosed $23.8M raised across 2 rounds.
Where is Genelux headquartered?
Genelux is headquartered in Westlake Village, US.